International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
Dombret, H., Seymour, J. F., Butrym, A., Wierzbowska, A., Selleslag, D., Jang, J. H., Kumar, R., Cavenagh, J., Schuh, A. C., Candoni, A., Recher, C., Sandhu, I., Bernal del Castillo, T., Al-Ali, H. K.Volume:
126
Language:
english
Journal:
Blood
DOI:
10.1182/blood-2015-01-621664
Date:
July, 2015
File:
PDF, 4.62 MB
english, 2015